ELAN CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 970 JPY | +3.30% |
|
+7.42% | -13.08% |
Strengths
- Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 59% by 2026.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is not the most generous with respect to shareholders' compensation.
Ratings chart - Surperformance
Sector: Healthcare Facilities & Services
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -13.08% | 363M | - | ||
| +17.70% | 83.07B | C+ | ||
| -29.71% | 70.89B | B- | ||
| +3.59% | 28.32B | C+ | ||
| -7.84% | 17.73B | B | ||
| +2.07% | 17.43B | A- | ||
| +0.48% | 15.64B | A- | ||
| +7.89% | 13.46B | B- | ||
| +8.40% | 12.82B | A- | ||
| +69.68% | 12.69B | C- |
Investor Rating
Trading Rating
-
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
-
Profitability
Finances
-
Valuation
P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
-
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
-
4m Target Price Revision
-
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
-
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- 6099 Stock
- Ratings Elan Corporation
